https://www.marketscreener.com/quote/stock/CHECKMATE-PHARMACEUTICALS-110594700/news/Checkmate-Pharmaceuticals-Presents-Clinical-Trial-Biomarker-Data-with-Vidutolimod-at-the-2022-Americ-40008402/?utm_source=telegram&utm_medium=social&utm_campaign=share